Join our live webinar to explore the frontiers of research on B cells and antibody repertoires in cancer
There is significant interest in the role of B cells in cancer. With an increasing demand for antibody and cell-based therapeutics, a deeper understanding of the immune system and cancer genomics has become more crucial than ever. By studying B cells and immune repertoires, researchers are able to discover more nuanced and targeted therapies against cancer.
Join industry experts Dr. Dmitriy M. Chudakov, CSO at MiLaboratories LLC, and Dr. Nicola Bonzanni, CSO at ENPICOM, for an in-depth discussion on what we can learn from B cells and antibody repertoires to advance cell and gene therapies. The speakers will highlight recent advancements in B cell research and cutting-edge software solutions for analyzing antibody repertoires.
Attend this webinar to explore:
- Roles of B cells in cancer
- The use of antibody repertoires in tumor samples
- How to address challenges of intratumoral clonal heterogeneity
- The use of cutting-edge technologies to leverage the full potential of antibody sequencing data
Get all these insights and more with this 45-minute session followed by a live Q&A.
Register here to watch the recording
Meet the speakers:
Dr. Dmitriy M. Chudakov
Co-founder and CSO @MiLaboratories LLC
Dr. Chudakov’s work focuses on clonal T cell and B cell populations in autoimmunity and cancer, DNA technologies, and software development for quantitative analysis of TCR and antibody repertoires. In addition to leading adaptive immunity research in some of the biggest universities in Russia and Czech Republic, Dr. Dmitriy M. Chudakov serves an Associate Prof. at Skolkovo Institute of Science and Technology (Moscow, Russia) where he studies the basics of adaptive immunity in health and disease.
Dr. Nicola Bonzanni
Co-founder and CSO @ENPICOM
As Chief Scientific Officer at ENPICOM, Dr. Bonzanni uses his passion for science and technology to close the gap between life sciences, software engineering, and data visualization to empower life scientists with state-of-the-art computational software solutions. He manages the scientific team with bioinformaticians, computational immunologists, scientific project managers, and product managers.